Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 45 AND POTASSIUM CHLORIDE 20MEQ K IN PLASTIC CONTAINER versus MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 45 AND POTASSIUM CHLORIDE 20MEQ K IN PLASTIC CONTAINER versus MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER.
DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER vs MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides a source of calories and is metabolized to carbon dioxide and water, producing energy. Sodium chloride maintains electrolyte balance and osmotic pressure. Potassium chloride replaces potassium for cellular ion exchange and acid-base balance.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Intravenous infusion. Dosing is individualized based on fluid, electrolyte, and caloric requirements. Typical adult maintenance dose: 1-3 L/day at a rate of 50-125 mL/hour. Maximum infusion rate: 0.5 g/kg/hour for glucose; potassium infusion rate should not exceed 10 mEq/hour or 200 mEq/day in adults.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
None Documented
None Documented
Dextrose: ~15-20 min (rapid uptake into cells). Potassium: ~8-12 h (redistribution half-life ~1 h; terminal elimination depends on renal function, clinical context: prolonged in renal impairment).
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Renal: >95% of dextrose (as CO2 via respiration) and sodium and chloride (with water); potassium excreted renally, ~90% reabsorbed, distal secretion under aldosterone control. Minimal fecal/biliary.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Category A/B
Category C
Electrolyte
Electrolyte